216 related articles for article (PubMed ID: 2535754)
1. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element.
Boral AL; Okenquist SA; Lenz J
J Virol; 1989 Jan; 63(1):76-84. PubMed ID: 2535754
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
Morrison HL; Dai HY; Pedersen FS; Lenz J
J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
[TBL] [Abstract][Full Text] [Related]
4. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
[TBL] [Abstract][Full Text] [Related]
5. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
Lovmand J; Sorensen AB; Schmidt J; Ostergaard M; Luz A; Pedersen FS
J Virol; 1998 Jul; 72(7):5745-56. PubMed ID: 9621033
[TBL] [Abstract][Full Text] [Related]
6. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
Nieves A; Levy LS; Lenz J
J Virol; 1997 Feb; 71(2):1213-9. PubMed ID: 8995644
[TBL] [Abstract][Full Text] [Related]
7. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
Pantginis J; Beaty RM; Levy LS; Lenz J
J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
[TBL] [Abstract][Full Text] [Related]
8. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.
Lenz J; Celander D; Crowther RL; Patarca R; Perkins DW; Haseltine WA
Nature; 1984 Mar 29-Apr 4; 308(5958):467-70. PubMed ID: 6323995
[TBL] [Abstract][Full Text] [Related]
9. Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness.
Celander D; Hsu BL; Haseltine WA
J Virol; 1988 Apr; 62(4):1314-22. PubMed ID: 2831392
[TBL] [Abstract][Full Text] [Related]
10. Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL3-2 contribute to cell-dependent gene expression.
Dai HY; Etzerodt M; Baekgaard AJ; Lovmand S; Jørgensen P; Kjeldgaard NO; Pedersen FS
Virology; 1990 Apr; 175(2):581-5. PubMed ID: 2158188
[TBL] [Abstract][Full Text] [Related]
11. Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses.
Yoshimura FK; Tupper J; Diem K
J Virol; 1989 Nov; 63(11):4945-8. PubMed ID: 2552174
[TBL] [Abstract][Full Text] [Related]
12. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.
Hallberg B; Schmidt J; Luz A; Pedersen FS; Grundström T
J Virol; 1991 Aug; 65(8):4177-81. PubMed ID: 1649324
[TBL] [Abstract][Full Text] [Related]
13. Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus.
Morrison HL; Soni B; Lenz J
J Virol; 1995 Jan; 69(1):446-55. PubMed ID: 7983741
[TBL] [Abstract][Full Text] [Related]
14. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
15. Localization of the leukemogenic determinants of SL3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin.
Lenz J; Haseltine WA
J Virol; 1983 Aug; 47(2):317-28. PubMed ID: 6312068
[TBL] [Abstract][Full Text] [Related]
16. Tissue specific sequence motifs in the enhancer of the leukaemogenic mouse retrovirus SL3-3.
Hallberg B; Grundström T
Nucleic Acids Res; 1988 Jul; 16(13):5927-44. PubMed ID: 2840634
[TBL] [Abstract][Full Text] [Related]
17. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
18. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
19. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
[TBL] [Abstract][Full Text] [Related]
20. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
Martiney MJ; Levy LS; Lenz J
J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]